StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
25
This month
1
This week
1
This year
2
Yesterday
1
Publishing Date
2024 - 04 - 23
1
2024 - 03 - 07
1
2023 - 11 - 17
1
2023 - 06 - 21
1
2022 - 03 - 01
2
2022 - 01 - 20
1
2021 - 12 - 03
1
2021 - 09 - 15
1
2021 - 08 - 17
1
2021 - 07 - 26
1
2021 - 07 - 09
1
2021 - 06 - 23
2
2021 - 05 - 28
1
2021 - 05 - 21
1
2021 - 05 - 20
1
2021 - 05 - 07
1
2021 - 05 - 05
1
2021 - 04 - 23
1
2021 - 04 - 22
1
2021 - 04 - 16
1
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 07
1
Sector
Health technology
25
N/a
4
Tags
Alliances
9
Antibody
5
Application
10
Approval
25
Asco
6
Asia
7
Association
6
Biocanada
9
Biotech-bay
15
Biotech-beach
6
Biotechnology
17
Brukinsa
17
Cancer
59
Cell
5
China
19
Clinical-trials-phase-ii
9
Clinical-trials-phase-iii
11
Collaboration
14
Conference
22
Dkn-01
6
Drug
5
Earnings
16
Europe
5
Events
22
Fda
16
Financial
16
Financial results
12
Genetown
16
Global
6
Health
5
Leap
13
Leukemia
11
License
10
Lumakras
12
Lung
7
Lung cancer
10
Meeting
10
N/a
132
Offering
6
People
8
Pharmaceutical
6
Pharmaceuticals
11
Phase 2
8
Phase 3
8
Pipeline
8
Plus
6
Positive
19
Product-news
9
Regulatory
8
Report
9
Research
23
Results
50
Study
9
Therapeutics
31
Therapy
8
Topline
8
Treatment
17
Trial
23
Update
6
Year
8
Entities
Abbvie inc.
10
Adc therapeutics sa
5
Agios pharmaceuticals, inc.
10
Alnylam pharmaceuticals, inc.
10
Amgen inc.
14
Aveo pharmaceuticals, inc.
10
Beigene, ltd.
25
Blueprint medicines corporation
10
Bristol-myers squibb company
10
Chemocentryx, inc.
1
Clovis oncology, inc.
10
Eli lilly and company
10
Epizyme, inc.
10
Exelixis, inc.
10
Hutchison china meditech limited
1
Illumina, inc.
10
Incyte corporation
10
Karyopharm therapeutics inc.
10
Pfizer, inc.
10
Regeneron pharmaceuticals, inc.
10
Rigel pharmaceuticals, inc.
10
Sanofi
10
Verastem, inc.
10
Y-mabs therapeutics, inc.
10
Symbols
ABBV
37
ABT
25
ADCT
19
ADMA
17
AGIO
11
ALNY
13
AMGN
22
AMPH
9
AMRX
16
ANIP
17
ARGX
10
ARVL
14
ATLC
8
AVEO
20
BCRX
16
BGNE
25
BHC
8
BIIB
20
BMY
48
BPMC
23
BSX
8
CALT
8
CLVS
19
CNSP
11
EPZM
18
EXEL
14
FNCTF
21
FRG
15
GH
12
GILD
16
GSK
10
HALO
9
ILMN
12
IMAB
8
INCY
41
JAGX
8
JAZZ
8
JNJ
95
KMDA
11
KPTI
31
LLY
46
LTUM
11
MDT
28
MRK
8
NVAX
10
NVS
21
NVSEF
13
PFE
31
PRGO
22
REGN
32
RETA
9
RIGL
11
SNY
98
SNYNF
64
TAK
21
TEVJF
13
VRTX
8
VSTM
10
VTRS
8
YMAB
19
Exchanges
Nasdaq
25
Nyse
10
Crawled Date
2024 - 04 - 23
1
2024 - 03 - 07
1
2023 - 11 - 17
1
2023 - 06 - 21
1
2022 - 03 - 01
2
2022 - 01 - 20
1
2021 - 12 - 03
1
2021 - 09 - 15
1
2021 - 08 - 17
1
2021 - 07 - 26
1
2021 - 07 - 09
1
2021 - 06 - 23
2
2021 - 05 - 28
1
2021 - 05 - 21
1
2021 - 05 - 20
1
2021 - 05 - 07
1
2021 - 05 - 05
1
2021 - 04 - 23
1
2021 - 04 - 22
1
2021 - 04 - 16
1
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 07
1
Crawled Time
08:00
1
09:00
3
10:00
2
11:00
2
12:00
4
13:50
1
14:20
1
16:00
1
17:37
1
18:04
1
18:26
1
18:31
2
18:33
1
18:40
1
18:42
1
20:59
1
23:00
1
Source
www.biospace.com
14
www.fda.gov
10
www.globenewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Approval
symbols :
Bgne
save search
BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
Published:
2024-04-23
(Crawled : 12:00)
- biospace.com/
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
5.97%
|
O:
3.5%
H:
4.77%
C:
2.39%
lung
approval
cancer
cell
treatment
for
BeiGene Announces FDA Accelerated Approval of BRUKINSA for the Treatment of Relapsed or Refractory Follicular Lymphoma
Published:
2024-03-07
(Crawled : 23:00)
- biospace.com/
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-12.87%
|
O:
-0.93%
H:
3.2%
C:
2.66%
fda
brukinsa
approval
treatment
BeiGene Receives European Commission Approval for BRUKINSA® (zanubrutinib) for the Treatment of Relapsed or Refractory Follicular Lymphoma
Published:
2023-11-17
(Crawled : 16:00)
- biospace.com/
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-26.53%
|
O:
0.0%
H:
0.38%
C:
-1.21%
brukinsa
approval
treatment
FDA GRANTS FULL APPROVAL FOR BLINCYTO® (BLINATUMOMAB) TO TREAT MINIMAL RESIDUAL DISEASE-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Published:
2023-06-21
(Crawled : 14:20)
- biospace.com/
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-27.45%
|
O:
-0.8%
H:
0.36%
C:
-2.33%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
19.66%
|
O:
-0.18%
H:
0.8%
C:
-0.5%
blincyto
fda
approval
treat
grants
leukemia
HUTCHMED Receives Approval to Commercialize ELUNATE® in MacauFirst homegrown innovative medicine approved in Macau based on China clinical data
Published:
2022-03-01
(Crawled : 11:00)
- biospace.com/
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-32.63%
|
O:
1.97%
H:
0.0%
C:
0.0%
elunate
approval
china
commercialization
HUTCHMED Receives Approval to Commercialize ELUNATE® in Macau
Published:
2022-03-01
(Crawled : 09:00)
- globenewswire.com
HCM
|
$18.405
0.85%
0.84%
58K
|
Health Technology
|
-32.29%
|
O:
1.17%
H:
4.14%
C:
2.64%
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-32.63%
|
O:
1.97%
H:
0.0%
C:
0.0%
elunate
approval
commercialization
LUMAKRAS® (sotorasib) Receives Approval In Japan For Patients With KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer
Published:
2022-01-20
(Crawled : 11:00)
- biospace.com/
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-41.74%
|
O:
3.95%
H:
2.8%
C:
1.37%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
17.03%
|
O:
-0.0%
H:
0.0%
C:
-2.07%
lumakras
approval
cel
lung cancer
cancer
BeiGene and EUSA Pharma Announce NMPA Approval of SYLVANT® (Siltuximab for Injection) in China for Idiopathic Multicentric Castleman Disease
Published:
2021-12-03
(Crawled : 08:00)
- biospace.com/
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-60.78%
|
O:
-0.98%
H:
0.0%
C:
0.0%
ema
approval
disease
china
injection
U.S. FDA Grants BRUKINSA® (Zanubrutinib) Accelerated Approval in Relapsed or Refractory Marginal Zone Lymphoma
Published:
2021-09-15
(Crawled : 12:00)
- biospace.com/
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-62.32%
|
O:
2.2%
H:
1.82%
C:
-0.44%
fda
brukinsa
approval
granted
grant
BeiGene and EUSA Pharma Announce China NMPA Approval of QARZIBA® (Dinutuximab Beta) for Patients with High-Risk Neuroblastoma
Published:
2021-08-17
(Crawled : 12:00)
- biospace.com/
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-50.46%
|
O:
-2.33%
H:
4.04%
C:
2.74%
risk
china
approval
pharma
BeiGene Announces Approval in Canada of BRUKINSA® (Zanubrutinib) for the Treatment of Patients with Mantle Cell Lymphoma
Published:
2021-07-26
(Crawled : 12:00)
- biospace.com/
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-56.28%
|
O:
-3.99%
H:
2.19%
C:
-10.03%
treatment
brukinsa
approval
BeiGene Announces the Approval in China of KYPROLIS® (Carfilzomib) for Injection for Adult Patients with Relapsed or Refractory Multiple Myeloma
Published:
2021-07-09
(Crawled : 09:00)
- biospace.com/
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-56.58%
|
O:
0.63%
H:
3.3%
C:
2.21%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
11.98%
|
O:
-0.49%
H:
1.17%
C:
0.87%
china
injection
approval
China NMPA Approves Tislelizumab in Non-Small Cell Lung Cancer and Hepatocellular Carcinoma
Published:
2021-06-23
(Crawled : 10:00)
- biospace.com/
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-58.2%
|
O:
0.74%
H:
2.99%
C:
2.16%
lung cancer
china
cancer
approval
Amgen Announces Approval Of Aimovig® (Erenumab) In Japan For The Suppression Of Onset Of Migraine Attacks In Adults
Published:
2021-06-23
(Crawled : 09:00)
- biospace.com/
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-58.2%
|
O:
0.74%
H:
2.99%
C:
2.16%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
14.02%
|
O:
-0.11%
H:
0.04%
C:
-0.39%
migraine
approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published:
2021-05-28
(Crawled : 18:31)
- fda.gov
ALNY
|
$143.8
-1.55%
-1.58%
390K
|
Health Technology
|
Email alert
Add to watchlist
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
Email alert
Add to watchlist
INCY
|
$51.72
0.14%
0.14%
1.5M
|
Health Technology
|
Email alert
Add to watchlist
VSTM
|
$9.29
-3.33%
-3.44%
79K
|
Health Technology
|
Email alert
Add to watchlist
EXEL
|
$23.7
1.76%
1.73%
1.5M
|
Health Technology
|
Email alert
Add to watchlist
YMAB
|
$15.26
-0.52%
-0.52%
160K
|
Health Technology
|
Email alert
Add to watchlist
KPTI
|
$1.1
0.92%
0.91%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
Email alert
Add to watchlist
ILMN
|
$122.74
-1.38%
-1.4%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
Email alert
Add to watchlist
BPMC
|
$92.31
0.02%
0.02%
560K
|
Health Technology
|
Email alert
Add to watchlist
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
Email alert
Add to watchlist
ADCT
|
$4.78
-3.82%
0.0%
280K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
RIGL
|
$1.125
-1.32%
-1.33%
6.4M
|
Health Technology
|
Email alert
Add to watchlist
AGIO
|
$31.67
-0.44%
-0.44%
540K
|
Health Technology
|
Email alert
Add to watchlist
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
Email alert
Add to watchlist
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
Email alert
Add to watchlist
cancer
approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published:
2021-05-21
(Crawled : 18:33)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-34.4%
|
O:
0.22%
H:
0.97%
C:
-0.65%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
270.4%
|
O:
0.24%
H:
0.96%
C:
-0.06%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-26.88%
|
O:
0.36%
H:
1.01%
C:
-0.28%
ADCT
|
$4.78
-3.82%
0.0%
280K
|
Health Technology
|
-75.73%
|
O:
2.54%
H:
0.48%
C:
-0.29%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
44.77%
|
O:
0.35%
H:
0.65%
C:
-1.19%
YMAB
|
$15.26
-0.52%
-0.52%
160K
|
Health Technology
|
-57.44%
|
O:
0.58%
H:
1.24%
C:
-1.66%
VSTM
|
$9.29
-3.33%
-3.44%
79K
|
Health Technology
|
201.25%
|
O:
0.63%
H:
2.49%
C:
-0.62%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-12.92%
|
O:
-0.43%
H:
0.2%
C:
0.02%
RIGL
|
$1.125
-1.32%
-1.33%
6.4M
|
Health Technology
|
-69.02%
|
O:
0.82%
H:
1.08%
C:
-1.62%
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
76.79%
|
O:
0.18%
H:
0.46%
C:
-1.44%
KPTI
|
$1.1
0.92%
0.91%
1.2M
|
Health Technology
|
-88.56%
|
O:
0.31%
H:
1.15%
C:
-1.46%
INCY
|
$51.72
0.14%
0.14%
1.5M
|
Health Technology
|
-38.15%
|
O:
0.57%
H:
0.6%
C:
-1.46%
ILMN
|
$122.74
-1.38%
-1.4%
1.2M
|
Health Technology
|
-68.61%
|
O:
0.33%
H:
2.2%
C:
0.21%
EXEL
|
$23.7
1.76%
1.73%
1.5M
|
Health Technology
|
-4.27%
|
O:
0.08%
H:
1.64%
C:
0.45%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-83.08%
|
O:
1.04%
H:
0.0%
C:
-2.62%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.37%
|
O:
0.95%
H:
1.31%
C:
-2.81%
BPMC
|
$92.31
0.02%
0.02%
560K
|
Health Technology
|
-3.29%
|
O:
1.12%
H:
0.84%
C:
-0.08%
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-59.61%
|
O:
0.1%
H:
1.6%
C:
0.88%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
115.45%
|
O:
1.19%
H:
1.71%
C:
-0.33%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
8.58%
|
O:
0.71%
H:
0.14%
C:
-1.06%
ALNY
|
$143.8
-1.55%
-1.58%
390K
|
Health Technology
|
4.26%
|
O:
0.38%
H:
1.01%
C:
-0.41%
AGIO
|
$31.67
-0.44%
-0.44%
540K
|
Health Technology
|
-43.96%
|
O:
0.86%
H:
1.27%
C:
-0.24%
cancer
approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published:
2021-05-20
(Crawled : 18:26)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-34.4%
|
O:
0.22%
H:
0.97%
C:
-0.65%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
270.4%
|
O:
0.24%
H:
0.96%
C:
-0.06%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-26.88%
|
O:
0.36%
H:
1.01%
C:
-0.28%
ADCT
|
$4.78
-3.82%
0.0%
280K
|
Health Technology
|
-75.73%
|
O:
2.54%
H:
0.48%
C:
-0.29%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
44.77%
|
O:
0.35%
H:
0.65%
C:
-1.19%
YMAB
|
$15.26
-0.52%
-0.52%
160K
|
Health Technology
|
-57.44%
|
O:
0.58%
H:
1.24%
C:
-1.66%
VSTM
|
$9.29
-3.33%
-3.44%
79K
|
Health Technology
|
201.25%
|
O:
0.63%
H:
2.49%
C:
-0.62%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-12.92%
|
O:
-0.43%
H:
0.2%
C:
0.02%
RIGL
|
$1.125
-1.32%
-1.33%
6.4M
|
Health Technology
|
-69.02%
|
O:
0.82%
H:
1.08%
C:
-1.62%
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
76.79%
|
O:
0.18%
H:
0.46%
C:
-1.44%
KPTI
|
$1.1
0.92%
0.91%
1.2M
|
Health Technology
|
-88.56%
|
O:
0.31%
H:
1.15%
C:
-1.46%
INCY
|
$51.72
0.14%
0.14%
1.5M
|
Health Technology
|
-38.15%
|
O:
0.57%
H:
0.6%
C:
-1.46%
ILMN
|
$122.74
-1.38%
-1.4%
1.2M
|
Health Technology
|
-68.61%
|
O:
0.33%
H:
2.2%
C:
0.21%
EXEL
|
$23.7
1.76%
1.73%
1.5M
|
Health Technology
|
-4.27%
|
O:
0.08%
H:
1.64%
C:
0.45%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-83.08%
|
O:
1.04%
H:
0.0%
C:
-2.62%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.37%
|
O:
0.95%
H:
1.31%
C:
-2.81%
BPMC
|
$92.31
0.02%
0.02%
560K
|
Health Technology
|
-3.29%
|
O:
1.12%
H:
0.84%
C:
-0.08%
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-59.61%
|
O:
0.1%
H:
1.6%
C:
0.88%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
115.45%
|
O:
1.19%
H:
1.71%
C:
-0.33%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
8.58%
|
O:
0.71%
H:
0.14%
C:
-1.06%
ALNY
|
$143.8
-1.55%
-1.58%
390K
|
Health Technology
|
4.26%
|
O:
0.38%
H:
1.01%
C:
-0.41%
AGIO
|
$31.67
-0.44%
-0.44%
540K
|
Health Technology
|
-43.96%
|
O:
0.86%
H:
1.27%
C:
-0.24%
cancer
approval
China NMPA Approves PARP Inhibitor Pamiparib for Patients with Previously Treated Advanced Ovarian Cancer
Published:
2021-05-07
(Crawled : 10:00)
- biospace.com/
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-55.74%
|
O:
2.26%
H:
1.96%
C:
-2.84%
china
cancer
ovarian cancer
approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published:
2021-05-05
(Crawled : 18:31)
- fda.gov
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-34.15%
|
O:
-3.73%
H:
1.95%
C:
1.85%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
283.3%
|
O:
-0.65%
H:
1.33%
C:
1.22%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-24.26%
|
O:
-0.12%
H:
0.19%
C:
-0.22%
ADCT
|
$4.78
-3.82%
0.0%
280K
|
Health Technology
|
-77.41%
|
O:
3.45%
H:
1.01%
C:
-0.66%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
46.43%
|
O:
-0.67%
H:
1.03%
C:
0.94%
YMAB
|
$15.26
-0.52%
-0.52%
160K
|
Health Technology
|
-45.8%
|
O:
-0.85%
H:
2.64%
C:
2.1%
VSTM
|
$9.29
-3.33%
-3.44%
79K
|
Health Technology
|
224.66%
|
O:
-2.03%
H:
0.82%
C:
-1.72%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-6.96%
|
O:
0.55%
H:
0.51%
C:
0.29%
RIGL
|
$1.125
-1.32%
-1.33%
6.4M
|
Health Technology
|
-67.15%
|
O:
0.0%
H:
0.0%
C:
-6.05%
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
88.08%
|
O:
0.14%
H:
4.11%
C:
3.22%
KPTI
|
$1.1
0.92%
0.91%
1.2M
|
Health Technology
|
-86.56%
|
O:
0.37%
H:
1.11%
C:
0.0%
INCY
|
$51.72
0.14%
0.14%
1.5M
|
Health Technology
|
-36.45%
|
O:
-0.09%
H:
1.99%
C:
1.35%
ILMN
|
$122.74
-1.38%
-1.4%
1.2M
|
Health Technology
|
-67.1%
|
O:
-0.64%
H:
0.34%
C:
0.31%
EXEL
|
$23.7
1.76%
1.73%
1.5M
|
Health Technology
|
-2.84%
|
O:
-0.88%
H:
0.34%
C:
-2.27%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-80.45%
|
O:
-0.27%
H:
0.0%
C:
-9.2%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.53%
|
O:
-0.34%
H:
0.86%
C:
-2.91%
BPMC
|
$92.31
0.02%
0.02%
560K
|
Health Technology
|
1.47%
|
O:
-0.26%
H:
2.88%
C:
2.72%
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-54.49%
|
O:
0.14%
H:
3.67%
C:
2.67%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
121.49%
|
O:
-0.3%
H:
0.15%
C:
-1.78%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
9.7%
|
O:
-0.03%
H:
0.88%
C:
0.81%
ALNY
|
$143.8
-1.55%
-1.58%
390K
|
Health Technology
|
10.1%
|
O:
-0.51%
H:
1.52%
C:
0.08%
AGIO
|
$31.67
-0.44%
-0.44%
540K
|
Health Technology
|
-40.29%
|
O:
-0.45%
H:
4.45%
C:
3.9%
cancer
approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published:
2021-04-23
(Crawled : 18:42)
- fda.gov
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
RIGL
|
$1.125
-1.32%
-1.33%
6.4M
|
Health Technology
|
Email alert
Add to watchlist
ILMN
|
$122.74
-1.38%
-1.4%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
Email alert
Add to watchlist
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
Email alert
Add to watchlist
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
Email alert
Add to watchlist
KPTI
|
$1.1
0.92%
0.91%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
ALNY
|
$143.8
-1.55%
-1.58%
390K
|
Health Technology
|
Email alert
Add to watchlist
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
Email alert
Add to watchlist
AGIO
|
$31.67
-0.44%
-0.44%
540K
|
Health Technology
|
Email alert
Add to watchlist
VSTM
|
$9.29
-3.33%
-3.44%
79K
|
Health Technology
|
Email alert
Add to watchlist
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
Email alert
Add to watchlist
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
Email alert
Add to watchlist
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
YMAB
|
$15.26
-0.52%
-0.52%
160K
|
Health Technology
|
Email alert
Add to watchlist
BPMC
|
$92.31
0.02%
0.02%
560K
|
Health Technology
|
Email alert
Add to watchlist
EXEL
|
$23.7
1.76%
1.73%
1.5M
|
Health Technology
|
Email alert
Add to watchlist
ADCT
|
$4.78
-3.82%
0.0%
280K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
INCY
|
$51.72
0.14%
0.14%
1.5M
|
Health Technology
|
Email alert
Add to watchlist
cancer
approval
← Previous
1
2
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.